論文・総説 - 宮﨑　泰成

221. Noguchi C, Umino T, Miyazaki Y, Jinta T, Usui Y, Yoshizawa Y. TGF-beta and glutathione promote tissue repair in cigarette smoke induced injury. J Med Dent Sci. 2007.03; 54 (1): 109-116. ( PubMed )

222. Tsuchiya K, Inase N, Ichinose S, Usui Y, Miyazaki Y, Ohtani Y, Ando N, Akashi T, Kondoh Y, Taniguchi H, Yoshizawa Y. Elemental analysis of inorganic dusts in lung tissues of interstitial pneumonias. J Med Dent Sci. 2007.03; 54 (1): 9-16. ( PubMed )

223. Yoshizawa Y, Miyazaki Y, Inase N, Otani Y, Isogai S, Furuie M, Kuramochi J, Kishi M, Jinta T. [Chronic hypersensitivity pneumonitis] Nippon Naika Gakkai Zasshi. 2006.09; 95 (9): 1904-1911. ( PubMed )

224. Yoshizawa Y, Miyazaki Y, Inase N, Otani Y, Isogai S, Furuie M, Kuramochi J, Kishi M, Jinta T. [Chronic hypersensitivity pneumonitis] Nippon Naika Gakkai Zasshi. 2006.06; 95 (6): 1004-1012. ( PubMed )

225. Watanabe J, Miyazaki Y, Zimmerman GA, Albertine KH, McIntyre TM. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J Biol Chem. 2003.10; 278 (43): 42361-42368. ( PubMed, DOI )

226. Inase N, Sawada M, Ohtani Y, Miyake S, Isogai S, Sakashita H, Miyazaki Y, Yoshizawa Y. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med. 2003.07; 42 (7): 565-570. ( PubMed )

227. Sumi Y, Kyi M, Miyazaki Y, Ohtani Y, Miyake S, Yoshizawa Y. Cytokine mRNA expression in isocyanate-induced hypersensitivity pneumonitis. Respiration. 2003.05; 70 (3): 284-291. ( PubMed, DOI )

228. Miyake S, Ohtani Y, Sawada M, Inase N, Miyazaki Y, Takano S, Miyasaka N, Yoshizawa Y. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis. 2002.06; 19 (2): 128-133. ( PubMed )

229. Kyi M, Miyazaki Y, Inoue T, Miyake S, Matsukawa A, Yoshizawa Y. Acute effects of smoke exposure on the cellular and cytokine profile in isolated perfused lungs. Respir Physiol. 2000.10; 123 (1-2): 143-151. ( PubMed )

230. Miyazaki Y, Sakashita H, Tanaka T, Kamei K, Nishimura K, Yoshizawa Y. Mucoid impaction caused by monokaryotic mycelium of Schizophyllum commune in association with bronchiectasis. Intern Med. 2000.02; 39 (2): 160-162. ( PubMed )

231. Ohtani Y, Yamaoka M, Sawada M, Miyazaki Y, Miyazaki R, Okayasu I, Yoshizawa Y. Acute intermittent porphyria associated with transient elevation of transaminases during an acute attack. Intern Med. 2000.01; 39 (1): 45-49. ( PubMed )

232. Miyazaki Y, Miyake S, Taki R, Ohkouchi Y, Matsubara O, Yoshizawa Y. Sarcoid reactions scattered in the tumor-bearing lung parenchyma and regional lymph nodes associated with pulmonary carcinoid. Intern Med. 1998.03; 37 (3): 304-306. ( PubMed )

233. Miyazaki Y, Inoue T, Kyi M, Sawada M, Miyake S, Yoshizawa Y. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFalpha) and activated neutrophils in isolated perfused rabbit lungs. Am J Respir Crit Care Med. 1998.01; 157 (1): 89-94. ( PubMed )

234. Yoshizawa Y, Miyashita Y, Inoue T, Sumi Y, Miyazaki Y, Sato T, Ohtsuka M. Sequential evaluation of clinical and immunological findings in hypersensitivity pneumonitis: serial subclass distribution of antibodies. Clin Immunol Immunopathol. 1994.12; 73 (3): 330-337. ( PubMed )

235. 古澤 春彦, 宮崎 泰成. 治療法の再整理とアップデートのために　専門家による私の治療　特発性間質性肺炎(特発性非特異性間質性肺炎,特発性器質化肺炎) 日本医事新報. 2024.11; (5247): 37-39. ( 医中誌 )

236. 石原 恵依子, 甲畑 宏子, 小峯 真理子, 荒井 裕国, 長岡 英気, 宮崎 泰成, 大友 康裕, 鵜川 豊世武, 増田 孝広, 神里 彩子, 吉田 雅幸. COVID-19の治療に関するインフォームド・コンセントにおける倫理的課題についての実態調査 生命倫理. 2024.09; 34 (1): 21-32. ( 医中誌 )

237. 望月 晶史, 本多 隆行, 宮崎 泰成, 河野 隆志. 間質性肺炎がもたらす肺発がんの分子機序　遺伝子変化と腫瘍微小環境の視点から 呼吸器内科. 2024.07; 46 (1): 85-89. ( 医中誌 )

238. 白井 剛, 宮崎 泰成. 【免疫・アレルギー性肺疾患と検査】疾患各論　過敏性肺炎 臨床検査. 2024.06; 68 (6): 693-698. ( 医中誌 )

239. 岡本 師, 宮崎 泰成. COVID-19とILD診療 呼吸器内科. 2023.12; 44 (6): 691-697. ( 医中誌 )

240. 本多 隆行, 望月 晶史, 河野 隆志, 宮崎 泰成. 間質性肺炎合併肺がんの発症機構 呼吸器内科. 2023.09; 44 (3): 322-328. ( 医中誌 )